This UK-based resource supports the monitoring and safe use of anti-tuberculosis drugs and second line treatment of MDR-TB. Its guidance team comprises Jessica L. Potter, Toby Capstick, William M. Ricketts, Nuala Whitehead and Onn Min Kon.
All documents can be found via their website here.
Mesothelioma is a rare type of lung cancer, typically caused by Asbestos inhalation and commonly...
The GIRFT Tuberculosis (TB) report is a comprehensive, data-driven national review of TB services...
In 2020 the COVID-19 pandemic hit the global population, causing lockdowns and economic...
This guideline covers diagnosing, assessing, and treating community-acquired and hospital-acquired...
COPD is the second most common cause for hospital admission and the third leading cause of death...